Kliogest N (Norethisterone Acetate, Estradiol)

The formulation delivers norethisterone acetate, a progestogen, together with estradiol, an estrogen. The pair suppresses the hypothalamic‑pituitary‑ovarian axis, preventing the luteinising hormone surge that triggers ovulation. Additionally, the progestogen thickens cervical mucus while the estrogen stabilises the endometrial lining, reducing the chance of fertilisation and implantation.

The specific dosing regimen for Kliogest N is determined by the prescribing healthcare professional. Typically, the product is taken as one tablet daily at the same time each day, but the exact schedule and duration should follow the prescriber’s instructions.

Kliogest N is contraindicated during pregnancy because it is intended to prevent conception. Women who become pregnant should discontinue use and seek medical advice. Limited data exist for breastfeeding; therefore, use while nursing should be discussed with a healthcare provider to weigh potential risks and benefits.

To order Kliogest N, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. The sales team will verify trade or institutional credentials, then respond with pricing, availability, shipping details and any necessary import documentation.

Kliogest N contains both norethisterone acetate and estradiol, offering a specific estrogen‑to‑progestogen ratio. Compared with other combined oral contraceptives that may use ethinyl estradiol or different progestins, Kliogest N may have a different side‑effect profile and metabolic impact. Choice of product should be individualized based on patient history, risk factors and physician preference.

Store Kliogest N tablets at room temperature, below 25 °C. Keep them in the original packaging to protect from moisture and light, and store out of reach of children. Do not refrigerate or freeze the tablets.

Kliogest N is taken orally as a tablet. It should be swallowed with water at the same time each day, with or without food. Consistent daily intake maintains hormone levels and maximises contraceptive effectiveness.

The most serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke or myocardial infarction, especially in women with cardiovascular risk factors. Severe liver dysfunction, jaundice, and allergic reactions are also critical concerns that require immediate medical attention.

Kliogest N is contraindicated in women with a history of thromboembolic disorders, uncontrolled hypertension, active liver disease, known or suspected breast cancer, or those who are pregnant. It should also be avoided by smokers over 35 years of age and by individuals taking strong enzyme‑inducing medications that reduce contraceptive efficacy.